Follow The Filings

ACON Aclarion

Aclarion earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ACON's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ACON insider trades
  • $177K bought by 7 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Amanda M Williams Director
    Buy
    $16K 5,857 shares at $2.73 +29% to stake
    Traded Aug 17 Filed Aug 19
    ↗
  2. Gregory A Gould CFO
    Buy
    $25K 10,000 shares at $2.45 +20% to stake
    Traded Aug 14 Filed Aug 18
    ↗
  3. Ryan Bond Director
    Buy
    $50K 21,122 shares at $2.37 +38% to stake
    Traded Aug 13 Filed Aug 17
    ↗
  4. William Wesemann Director
    Buy
    $5,031 2,150 shares at $2.34 +10% to stake
    Traded Aug 13 Filed Aug 17
    ↗
  5. David K Neal Director
    Buy
    $18K 7,500 shares at $2.40 +33% to stake
    Traded Aug 13 Filed Aug 17
    ↗
  6. Brent Ness CEO
    Buy
    $12K 5,234 shares at $2.31 +4.9% to stake
    Traded Aug 13 Filed Aug 17
    ↗
  7. Scott Breidbart Director
    Buy
    $18K 5,664 shares at $3.18 New stake
    Traded May 12 Filed May 12
    ↗
  8. David K Neal Director
    Buy
    $7,750 2,500 shares at $3.10 +125000% to stake
    Traded May 11 Filed May 12
    ↗
  9. Brent Ness CEO
    Buy
    $20K 6,289 shares at $3.18 +57173% to stake
    Traded May 11 Filed May 11
    ↗
  10. William Wesemann Director
    Buy
    $5,155 1,562 shares at $3.30 +156200% to stake
    Traded May 6 Filed May 8
    ↗
  11. Brent Ness CEO
    Buy
    $62 10 shares at $6.20 +1000% to stake
    Traded Nov 26, 2025 Filed Dec 1, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 9 stock grants.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
10-Q FORM 10-Q FOR JUN 2026 Filing Doc
8-K 5.07 Filing Doc
10-Q FORM 10-Q FOR MAR 2026 Filing Doc
DEF 14A NOTICE AND PROXY STATEMENT Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,3.03,5.03,8.01,9.01 Filing Doc
10-K FORM 10-K FOR DEC 2025 Filing Doc
8-K 7.01,9.01 Filing Doc
424B5 PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED 5-5-25 Filing Doc
8-K 1.01,9.01 Filing Doc
10-Q FORM 10-Q FOR SEP 2025 Filing Doc
424B5 FORM 424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 1.01,5.02,7.01,9.01 Filing Doc
10-Q FORM 10-Q FOR JUNE 2025 Filing Doc
8-K 5.07 Filing Doc
8-K 5.07,7.01,9.01 Filing Doc
DEFA14A SCHEDULE 14A DEFINITIVE ADDITIONAL MATERIALS Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.